< Back to companies
Genecast (臻和科技)

Genecast (臻和科技)

Wu Xi Shi, China

With next-generation sequencing technology and bioinformatics as the core, the Genecast is engaged in the precise diagnosis and attendant diagnosis of noninvasive-based oncology and is committed to becoming a leader in improving the quality of life of cancer patients. At present, Genecast has established an optimized platform for DNA extraction and quantitative detection technology, with the first China-based detection of multiple DNA-based solid tumors (lung cancer, colorectal cancer, liver cancer, esophageal cancer, endometrial cancer, ovarian cancer , Cervical cancer) with the diagnosis, prognosis, medication guidance technology platform.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2014
Website
www.genecast.com.cn/

Categories

CancerInformatics

Disease Areas

Technologies

Next-Generation SequencingBioinformaticsMolecular DiagnosticsDNA Sequencing
Only accessible to MedStartr community members. Join now

What do you think of Genecast (臻和科技)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now